title: Treatment of systemic sclerosis with tocilizumab.
authors.affiliation: Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
authors.forename: Marisa
authors.initials: M
authors.lastname: Fernandes das Neves
authors.affiliation: Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
authors.forename: Susana
authors.initials: S
authors.lastname: Oliveira
authors.affiliation: Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
authors.forename: Marta C
authors.initials: MC
authors.lastname: Amaral
authors.affiliation: Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal Immunomediated Systemic Diseases Unit, Medicine 4, Fernando Fonseca Hospital, Amadora and Center for Chronic Diseases (CEDOC), Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal jose.alves@fcm.unl.pt.
authors.forename: José
authors.initials: J
authors.lastname: Delgado Alves
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002908:Chronic Disease; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C502936:tocilizumab